(Q33395607)

English

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit